Home > Press > SMI awarded DOE Phase II SBIR to develop p-type ZnO
SMI awarded DOE Phase II SBIR to develop p-type ZnO
Posted on February 02, 2006
Structured Materials Industries, Inc. (SMI) has been awarded a Phase II SBIR by the Department of Energy to develop p-type doping of ZnO. ZnO has shown great promise as an alternative to GaN as a blue light emitter.
Critical to demonstrating blue light emission in this material system is development of p-n junctions. While n-type material is easily achieved, p-type material has been very elusive with only a few scattered reports and with repeatability issues.
CVD is believed to be one of the best approaches to achieving p-type doping because of its ability to produce high quality films, greatly vary the chemistry and produce atomically abrupt layers when needed. For this program SMI has built a dedicated MOCVD system which it operates in-house.
About Structured Materials Industries:
Structured Materials Industries, Incorporated is focused on being the leader in Metal Organic Chemical Vapor Deposition (MOCVD) and related technologies. SMI offers for sale: systems, components, materials, and process development services. SMI has an in-house applications laboratory featuring multi-reactor deposition systems and analytic capabilities, has developed a range of strategic partnerships to develop and implement MOCVD technology and looks forward to continuing to grow and expand upon mutually advantageous relationships.
For more information, please click here.
General and Technical Information this release:
Dr. Gary S. Tompa
Structured Materials Industries, Inc.
Unit 102/103, 201 Circle Drive N.
Piscataway, New Jersey 08854
Copyright © Structured Materials Industries
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Notes ABSMaterials' Series B Financing November 22nd, 2013
Harris & Harris Group Letter to Shareholders on Website November 18th, 2013
Harris & Harris Group Reports Financial Statements as of September 30, 2013 November 12th, 2013
Harris & Harris Group Notes CordenPharma's Acquisition of Ancora's Carbohydrate Synthesis Platform and Corporate Name November 7th, 2013
Turning waste into power with bacteria — and loofahs December 4th, 2013
High on Nano: Cannabinoid Nanoparticles to Treat the Primary Cause of Heart Attack and Stroke December 4th, 2013
Shapes of Things to Come: Exotic Shapes for Liquid Drops Have Many Possible Uses December 3rd, 2013
KAIST developed the biotemplated design of piezoelectric energy harvesting device December 3rd, 2013
Agilent Technologies Introduces Next-Generation Atomic Force Microscope December 3rd, 2013
Agilent Technologies’ Award-Winning, Ultrafast Express Test Now Compatible with All G200 Stages and DCM II, XP Heads December 3rd, 2013
AXT Appointed Exclusive Distributor for Fischione Instruments November 29th, 2013
New Malvern data demonstrate monoclonal antibody characterization using the Viscotek SEC-MALS 20 November 27th, 2013